Toxic shock syndrome: Difference between revisions
From IDWiki
No edit summary |
No edit summary |
||
(10 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
+ | == Background == |
||
− | * Severe septic shock caused by certain bacterial infections |
||
+ | * Severe septic shock caused by certain bacterial infections, primarily ''[[Staphylococcus aureus]]'' and ''[[Streptococcus pyogenes]]'' |
||
+ | ** Caused by superantigens, which non-specifically activate a massive number of T-cells |
||
+ | *Similar syndrome can be caused by toxin production of [[Clostridial toxic shock syndrome|''Clostridium sordelli'']] |
||
== Criteria == |
== Criteria == |
||
+ | {| class="wikitable" |
||
− | |||
− | {| |
||
! Criteria |
! Criteria |
||
− | ! Staphylococcal |
+ | ! [[Staphylococcal toxic shock syndrome|Staphylococcal]] |
− | ! Streptococcal |
+ | ! [[Streptococcal toxic shock syndrome|Streptococcal]] |
|- |
|- |
||
| Confirmed |
| Confirmed |
||
Line 57: | Line 59: | ||
|} |
|} |
||
+ | == Management == |
||
− | == Staphylococcal Toxic Shock Syndrome == |
||
+ | {| class="wikitable" |
||
− | |||
+ | ! |
||
− | Source: [https://wwwn.cdc.gov/nndss/conditions/toxic-shock-syndrome-other-than-streptococcal/case-definition/2011/ CDC case definition 2011] |
||
+ | !First-Line |
||
− | |||
+ | !Beta-lactam Allergy |
||
− | === Clinical Criteria === |
||
+ | !Notes |
||
− | |||
+ | |- |
||
− | An illness with the following clinical manifestations: |
||
+ | |[[Streptococcus pyogenes]] |
||
− | |||
+ | |[[Penicillin G]] and [[clindamycin]] |
||
− | * '''Fever:''' temperature greater than or equal to 102.0°F (greater than or equal to 38.9°C) |
||
+ | |[[Macrolide]] or [[fluoroquinolone]], and [[clindamycin]] |
||
− | * '''Rash:''' diffuse macular erythroderma |
||
+ | |Macrolide and fluoroquinolone resistance increasing |
||
− | * '''Desquamation:''' 1-2 weeks after onset of rash |
||
+ | |- |
||
− | * '''Hypotension:''' systolic blood pressure less than or equal to 90 mm Hg for adults or less than fifth percentile by age for children aged less than 16 years |
||
+ | |MLS-resistant [[Streptococcus pyogenes]] |
||
− | * '''Multisystem involvement''' (three or more of the following organ systems): |
||
+ | |[[Penicillin G]], and [[vancomycin]] or [[teicoplanin]] |
||
− | ** '''Gastrointestinal:''' vomiting or diarrhea at onset of illness |
||
+ | |[[Vancomycin]] or [[teicoplanin]] |
||
− | ** '''Muscular:''' severe myalgia or creatine phosphokinase level at least twice the upper limit of normal |
||
+ | |Macrolide resistance associated with clindamycin resistance |
||
− | ** '''Mucous membrane:''' vaginal, oropharyngeal, or conjunctival hyperemia |
||
+ | |- |
||
− | ** '''Renal:''' blood urea nitrogen or creatinine at least twice the upper limit of normal for laboratory or urinary sediment with pyuria (greater than or equal to 5 leukocytes per high-power field) in the absence of urinary tract infection |
||
+ | |Methicillin-susceptible [[Staphylococcus aureus]] |
||
− | ** '''Hepatic:''' total bilirubin, alanine aminotransferase enzyme, or asparate aminotransferase enzyme levels at least twice the upper limit of normal for laboratory |
||
+ | |[[Cloxacillin]] or [[nafcillin]] or [[cefazolin]], and [[clindamycin]] |
||
− | ** '''Hematologic:''' platelets less than 100,000/mm3 |
||
+ | |[[Clarithromycin]] and [[clindamycin]] |
||
− | ** '''Central nervous system:''' disorientation or alterations in consciousness without focal neurologic signs when fever and hypotension are absent |
||
+ | | |
||
− | |||
+ | |- |
||
− | === Laboratory Criteria for Diagnosis === |
||
+ | |Methicillin-resistant [[Staphylococcus aureus]] |
||
− | |||
+ | |[[Clindamycin]] or [[linezolid]], and [[vancomycin]] or [[teicoplanin]] |
||
− | Negative results on the following tests, if obtained: |
||
+ | | |
||
− | |||
+ | | |
||
− | * Blood or cerebrospinal fluid cultures (blood culture may be positive for Staphylococcus aureus) |
||
+ | |- |
||
− | * Negative serologies for Rocky Mountain spotted fever, leptospirosis, or measles |
||
+ | |Glycopeptide resistant or intermediate [[Staphylococcus aureus]] |
||
− | |||
+ | |[[Linezolid]] and [[clindamycin]] (if susceptible) |
||
− | === Case Classification === |
||
+ | | |
||
− | |||
+ | |Incidence increasing. Geographical patterns highly variable |
||
− | * Probable: A case which meets the laboratory criteria and in which four of the five clinical criteria described above are present |
||
+ | |} |
||
− | * Confirmed: A case which meets the laboratory criteria and in which all five of the clinical criteria described above are present, including desquamation, unless the patient dies before desquamation occurs |
||
− | |||
− | == Streptococcal Toxic Shock Syndrome == |
||
− | |||
− | Source: [https://wwwn.cdc.gov/nndss/conditions/streptococcal-toxic-shock-syndrome/case-definition/2010/ CDC case definition 2010] |
||
− | |||
− | === Clinical Description === |
||
− | |||
− | Streptococcal toxic shock syndrome (STSS) is a severe illness associated with invasive or noninvasive group A streptococcal (Streptococcus pyogenes) infection. STSS may occur with infection at any site but most often occurs in association with infection of a cutaneous lesion. Signs of toxicity and a rapidly progressive clinical course are characteristic, and the case fatality rate may exceed 50%. |
||
− | |||
− | === Clinical Criteria === |
||
− | |||
− | An illness with the following clinical manifestations*: |
||
− | |||
− | * '''Hypotension''' defined by a systolic blood pressure less than or equal to 90 mm Hg for adults or less than the fifth percentile by age for children aged less than 16 years. |
||
− | * '''Multi-organ involvement''' characterized by two or more of the following: |
||
− | ** '''Renal impairment:''' Creatinine greater than or equal to 2 mg/dL (greater than or equal to 177 µmol/L) for adults or greater than or equal to twice the upper limit of normal for age. In patients with preexisting renal disease, a greater than twofold elevation over the baseline level. |
||
− | ** '''Coagulopathy:''' Platelets less than or equal to 100,000/mm3 (less than or equal to 100 x 106/L) or disseminated intravascular coagulation, defined by prolonged clotting times, low fibrinogen level, and the presence of fibrin degradation products. |
||
− | ** '''Liver involvement:''' Alanine aminotransferase, aspartate aminotransferase, or total bilirubin levels greater than or equal to twice the upper limit of normal for the patient's age. In patients with preexisting liver disease, a greater than twofold increase over the baseline level. |
||
− | ** '''Acute respiratory distress syndrome:''' defined by acute onset of diffuse pulmonary infiltrates and hypoxemia in the absence of cardiac failure or by evidence of diffuse capillary leak manifested by acute onset of generalized edema, or pleural or peritoneal effusions with hypoalbuminemia. |
||
− | ** A '''generalized erythematous macular rash''' that may desquamate. |
||
− | ** '''Soft-tissue necrosis''', including necrotizing fasciitis or myositis, or gangrene. |
||
− | |||
− | * Clinical manifestations do not need to be detected within the first 48 hours of hospitalization or illness, as specified in the 1996 case definition. The specification of the 48 hour time constraint was for purposes of assessing whether the case was considered nosocomial, not whether it was a case or not. |
||
− | |||
− | === Laboratory Criteria for Diagnosis === |
||
− | |||
− | * Isolation of group A Streptococcus. |
||
− | + | == Further Reading == |
|
+ | * Gram-positive toxic shock syndromes. ''Lancet Infect Dis''. 2009;9(5):281-290. doi: [https://doi.org/10.1016/S1473-3099(09)70066-0 10.1016/S1473-3099(09)70066-0] |
||
− | * Probable: A case that meets the clinical case definition in the absence of another identified etiology for the illness and with isolation of group A Streptococcus from a non-sterile site. |
||
− | * Confirmed: A case that meets the clinical case definition and with isolation of group A Streptococcus from a normally sterile site (e.g., blood or cerebrospinal fluid or, less commonly, joint, pleural, or pericardial fluid). |
||
[[Category:Infectious syndromes]] |
[[Category:Infectious syndromes]] |
Latest revision as of 10:34, 22 November 2022
Background
- Severe septic shock caused by certain bacterial infections, primarily Staphylococcus aureus and Streptococcus pyogenes
- Caused by superantigens, which non-specifically activate a massive number of T-cells
- Similar syndrome can be caused by toxin production of Clostridium sordelli
Criteria
Criteria | Staphylococcal | Streptococcal |
---|---|---|
Confirmed | hypotension + fever + rash + desquamating + 3 or more other | hypotension + 2 or more other |
Hypotension | SBP ≤90 mmHg | SBP ≤90 mmHg |
Fever | temp ≥38.9ºC | |
Skin | diffuse macular erythroderma followed by desquamation | generalized erythematous macular rash that may desquamate |
GI | n/v/d at onset | |
Resp | ARDS | |
MSK | myalgia ± CK ≥2x ULN | soft-tissue necrosis (e.g. nec.fasc) |
Mucosa | hyperemia of any mucosa | |
Nephro | Creatinine ≥2x ULN, or pyuria without UTI |
Creatinine ≥177 or ≥2x ULN or ≥2x baseline |
Hepatic | bili/ALT/AST ≥2x ULN | ALT/AST/bili ≥2x ULN or ≥2x baseline |
Heme | thrombocytopenia <100 | thrombocytopenia ≤100, or DIC (INR/fibrinogen/D-dimer) |
CNS | altered LOC without focal signs |
Management
First-Line | Beta-lactam Allergy | Notes | |
---|---|---|---|
Streptococcus pyogenes | Penicillin G and clindamycin | Macrolide or fluoroquinolone, and clindamycin | Macrolide and fluoroquinolone resistance increasing |
MLS-resistant Streptococcus pyogenes | Penicillin G, and vancomycin or teicoplanin | Vancomycin or teicoplanin | Macrolide resistance associated with clindamycin resistance |
Methicillin-susceptible Staphylococcus aureus | Cloxacillin or nafcillin or cefazolin, and clindamycin | Clarithromycin and clindamycin | |
Methicillin-resistant Staphylococcus aureus | Clindamycin or linezolid, and vancomycin or teicoplanin | ||
Glycopeptide resistant or intermediate Staphylococcus aureus | Linezolid and clindamycin (if susceptible) | Incidence increasing. Geographical patterns highly variable |
Further Reading
- Gram-positive toxic shock syndromes. Lancet Infect Dis. 2009;9(5):281-290. doi: 10.1016/S1473-3099(09)70066-0